Valuation: Perrigo Company plc

Market Cap 1.89B 32.45B 1.64B 1.55B 1.41B 2.64B 182B 2.66B 18.5B 7.13B 92.1B 7.11B 6.96B 293B P/E 2026 *
1,365x
P/E 2027 * 11.4x
Enterprise Value 4.8B 82.21B 4.16B 3.92B 3.56B 6.68B 460B 6.73B 46.87B 18.06B 233B 18.02B 17.63B 742B EV / Sales 2026 *
1.18x
EV / Sales 2027 * 1.14x
Free-Float
99.6%
Yield 2026 *
8.47%
Yield 2027 * 8.69%
3 years 557.52
Extreme 557.52
557.52
5 years 557.52
Extreme 557.52
852.8
10 years 557.52
Extreme 557.52
1,299.45
Manager TitleAgeSince
Chief Executive Officer 63 2026-06-06
Director of Finance/CFO 51 2022-05-15
Chief Operating Officer - 2025-06-22
Director TitleAgeSince
Director/Board Member 75 2014-10-31
Director/Board Member 61 2016-11-06
Director/Board Member 70 2017-02-05
Change 5-day change 1-year change 3-year change Capi.($)
-18.73%-.--% - - 1.89B
+2.02%-0.96%+50.69%+92.40% 1,015B
+0.28%-3.24%+49.57%+62.65% 642B
+1.81%+2.07%+19.89%+70.38% 463B
+5.00%+2.21%+36.64%+39.24% 353B
+1.68%-9.20%+15.25%+24.87% 265B
+3.81%+0.93%+3.05%+12.39% 254B
+1.10%-12.75%+38.03%+45.44% 206B
+1.43%-6.21%-19.49%-58.94% 191B
+1.87%-3.04%+27.81%+89.26% 182B
Average -0.07%-3.35%+24.60%+41.97% 396.69B
Weighted average by Cap. +1.61%-2.21%+33.43%+57.25%

Financials

2026 *2027 *
Net sales 4.06B 69.54B 3.52B 3.32B 3.01B 5.65B 389B 5.69B 39.64B 15.28B 197B 15.25B 14.91B 628B 4.09B 70.05B 3.54B 3.34B 3.03B 5.69B 392B 5.73B 39.94B 15.39B 199B 15.36B 15.02B 632B
Net income -224M -3.84B -194M -183M -166M -312M -21.48B -314M -2.19B -843M -10.9B -842M -823M -34.64B -56.95M -976M -49.35M -46.57M -42.25M -79.25M -5.46B -79.83M -556M -214M -2.77B -214M -209M -8.8B
Net Debt 2.9B 49.76B 2.52B 2.38B 2.15B 4.04B 278B 4.07B 28.37B 10.93B 141B 10.91B 10.67B 449B 2.78B 47.69B 2.41B 2.28B 2.07B 3.87B 267B 3.9B 27.19B 10.48B 135B 10.46B 10.22B 430B
Logo Perrigo Company plc
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
8,100
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
13.65USD
Average target price
16.50USD
Spread / Average Target
+20.88%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!